JAZZ

$0.00

(

0.00%

)
Quote details

stock

Jazz Pharmaceuticals PLC

NASDAQ | JAZZ

127.00

USD

$0.00

(

0.00%

)

At Close (As of Sep 26, 2025)

$7.75B

Market Cap

-

P/E Ratio

-6.93

EPS

$148.06

52 Week High

$95.49

52 Week Low

HEALTHCARE

Sector

JAZZ Chart

Recent Chart
Price Action

JAZZ Technicals

Tags:

JAZZ Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $3.6B
Total Revenue $4.1B
Cost Of Revenue $446M
Costof Goods And Services Sold $446M
Operating Income $717M
Selling General And Administrative $1.4B
Research And Development $884M
Operating Expenses $2.9B
Investment Income Net -
Net Interest Income -$238M
Interest Income -
Interest Expense $238M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $660M
Income Before Tax $469M
Income Tax Expense -$91M
Interest And Debt Expense -
Net Income From Continuing Operations $560M
Comprehensive Income Net Of Tax -
Ebit $862M
Ebitda $1.5B
Net Income $560M

Revenue & Profitability

Earnings Performance

JAZZ Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $12B
Total Current Assets $4.6B
Cash And Cash Equivalents At Carrying Value $2.4B
Cash And Short Term Investments $2.4B
Inventory $480M
Current Net Receivables $717M
Total Non Current Assets $7.4B
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $4.8B
Intangible Assets Excluding Goodwill $4.8B
Goodwill $1.7B
Investments -
Long Term Investments -
Short Term Investments $580M
Other Current Assets $439M
Other Non Current Assets -
Total Liabilities $7.9B
Total Current Liabilities $1B
Current Accounts Payable $78M
Deferred Revenue -
Current Debt -
Short Term Debt $46M
Total Non Current Liabilities $6.9B
Capital Lease Obligations $54M
Long Term Debt $6.1B
Current Long Term Debt $31M
Long Term Debt Noncurrent -
Short Long Term Debt Total $6.2B
Other Current Liabilities $896M
Other Non Current Liabilities $87M
Total Shareholder Equity $4.1B
Treasury Stock -
Retained Earnings $1.1B
Common Stock $61K
Common Stock Shares Outstanding $66M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $1.4B
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $660M
Capital Expenditures $48M
Change In Receivables -
Change In Inventory -$46M
Profit Loss -
Cashflow From Investment -$508M
Cashflow From Financing $21M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$311M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $560M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $3.6B
Total Revenue $4.1B
Cost Of Revenue $446M
Costof Goods And Services Sold $446M
Operating Income $717M
Selling General And Administrative $1.4B
Research And Development $884M
Operating Expenses $2.9B
Investment Income Net -
Net Interest Income -$238M
Interest Income -
Interest Expense $238M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $660M
Income Before Tax $469M
Income Tax Expense -$91M
Interest And Debt Expense -
Net Income From Continuing Operations $560M
Comprehensive Income Net Of Tax -
Ebit $862M
Ebitda $1.5B
Net Income $560M

JAZZ News

JAZZ Profile

Jazz Pharmaceuticals PLC Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Jazz Pharmaceuticals plc is a leading biopharmaceutical company focused on identifying, developing, and commercializing innovative pharmaceutical products that address significant unmet medical needs across a range of therapeutic areas, including neurology, rare diseases, and hematology. Headquartered in Dublin, Ireland, Jazz leverages its global reach to provide solutions in the United States, Europe, and beyond, positioning itself as a critical player in advancing patient care. With a robust pipeline and a commitment to research and development, Jazz Pharmaceuticals aims to improve the lives of patients through targeted therapies and strategic partnerships.

DVLT
+30.57%
$1.09
INTC
+4.44%
$35.50
GPUS
+19.56%
$0.45
CGBS
-39.47%
$0.03
DFLI
+38.45%
$0.52
YAAS
-31.07%
$0.06
SNAP
-0.72%
$8.27
NEHC
+33.33%
$1.84
NUAI
+33.33%
$1.84
CJET
+10.63%
$0.17
NVDA
+0.28%
$178.19
F
+3.35%
$12.01
PSTV
+9.60%
$0.61
DNN
-3.14%
$2.77
APLT
+121.34%
$1.24
TSLA
+4.01%
$440.40
RGTI
-2.86%
$31.18
BIAF
+55.13%
$5.29
PLUG
+0.42%
$2.37
CIFR
-1.62%
$11.47
NIO
-5.75%
$7.04
ADAP
+15.74%
$0.14
WOK
-5.22%
$0.08
AAL
-0.70%
$11.31
RIG
+0.94%
$3.19
IONZ
+5.83%
$4.34
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
MRM
+102.75%
$2.94
QBTS
+1.59%
$26.76
VALE
-1.74%
$10.70
IREN
-9.57%
$41.86
BTG
+1.44%
$4.92
BLMZ
+12.51%
$0.20
QUBT
-2.11%
$20.14
MARA
+0.37%
$16.13
KVUE
+1.54%
$16.42
RIOT
+5.67%
$17.69
KDLY
+7.69%
$1.26
ATCH
-4.25%
$0.79
AAPL
-0.54%
$255.46
SOUN
-2.50%
$15.94
PLTR
-0.86%
$177.57
BITF
-5.22%
$2.54
BBD
+0.91%
$3.30
TLRY
-3.36%
$1.14
WBD
-1.36%
$19.51
AMZN
+0.74%
$219.78
FCX
+1.16%
$35.75
BURU
-10.14%
$0.12
BMNR
+1.87%
$50.50
IXHL
-0.01%
$0.59
ETHD
-6.19%
$3.94
RMBL
+60.50%
$3.21
RXRX
+1.94%
$4.72
SHOT
+12.24%
$0.28
RR
+2.68%
$4.20
GRAB
-2.24%
$6.11
ADD
-25.47%
$0.05
RAYA
-3.15%
$0.04
RIVN
-0.95%
$15.59
SOFI
-0.49%
$27.98
ONDS
-1.16%
$7.66
BULL
+3.55%
$15.16
CVE
+0.39%
$17.77
CLSK
-5.26%
$12.96
SRM
+53.27%
$10.30
ACHR
-0.53%
$9.27
PFE
+0.67%
$23.76
IONQ
-3.09%
$67.28
BB
+6.66%
$4.96
JOBY
+1.57%
$16.11
NOK
-0.42%
$4.66
AMD
-1.12%
$159.46
CRWV
-4.98%
$120.34
CLF
+2.48%
$12.37
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BTE
+2.43%
$2.52
QS
+1.28%
$12.66
WLGS
-5.57%
$0.04
HIMS
+6.43%
$58.40
AQMS
+48.37%
$7.30
ABEV
0.00%
$2.29
MRVL
-0.76%
$83.17
ETWO
0.00%
$3.30
ORCL
-2.70%
$283.45
HBAN
+0.57%
$17.42
HOOD
-0.70%
$121.78
AG
+4.02%
$12.14
NWTN
-15.63%
$2.04
AIIO
-15.63%
$2.04
SDM
-86.40%
$1.85
T
+0.03%
$28.31
OKLO
-7.21%
$110.53
ITUB
+0.55%
$7.24
MU
+0.28%
$157.27
PCG
+3.67%
$14.97
AFMD
-34.94%
$0.18
WULF
-1.27%
$10.83
DVLT
+30.57%
$1.09
INTC
+4.44%
$35.50
GPUS
+19.56%
$0.45
CGBS
-39.47%
$0.03
DFLI
+38.45%
$0.52
YAAS
-31.07%
$0.06
SNAP
-0.72%
$8.27
NEHC
+33.33%
$1.84
NUAI
+33.33%
$1.84
CJET
+10.63%
$0.17
NVDA
+0.28%
$178.19
F
+3.35%
$12.01
PSTV
+9.60%
$0.61
DNN
-3.14%
$2.77
APLT
+121.34%
$1.24
TSLA
+4.01%
$440.40
RGTI
-2.86%
$31.18
BIAF
+55.13%
$5.29
PLUG
+0.42%
$2.37
CIFR
-1.62%
$11.47
NIO
-5.75%
$7.04
ADAP
+15.74%
$0.14
WOK
-5.22%
$0.08
AAL
-0.70%
$11.31
RIG
+0.94%
$3.19
IONZ
+5.83%
$4.34
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
MRM
+102.75%
$2.94
QBTS
+1.59%
$26.76
VALE
-1.74%
$10.70
IREN
-9.57%
$41.86
BTG
+1.44%
$4.92
BLMZ
+12.51%
$0.20
QUBT
-2.11%
$20.14
MARA
+0.37%
$16.13
KVUE
+1.54%
$16.42
RIOT
+5.67%
$17.69
KDLY
+7.69%
$1.26
ATCH
-4.25%
$0.79
AAPL
-0.54%
$255.46
SOUN
-2.50%
$15.94
PLTR
-0.86%
$177.57
BITF
-5.22%
$2.54
BBD
+0.91%
$3.30
TLRY
-3.36%
$1.14
WBD
-1.36%
$19.51
AMZN
+0.74%
$219.78
FCX
+1.16%
$35.75
BURU
-10.14%
$0.12
BMNR
+1.87%
$50.50
IXHL
-0.01%
$0.59
ETHD
-6.19%
$3.94
RMBL
+60.50%
$3.21
RXRX
+1.94%
$4.72
SHOT
+12.24%
$0.28
RR
+2.68%
$4.20
GRAB
-2.24%
$6.11
ADD
-25.47%
$0.05
RAYA
-3.15%
$0.04
RIVN
-0.95%
$15.59
SOFI
-0.49%
$27.98
ONDS
-1.16%
$7.66
BULL
+3.55%
$15.16
CVE
+0.39%
$17.77
CLSK
-5.26%
$12.96
SRM
+53.27%
$10.30
ACHR
-0.53%
$9.27
PFE
+0.67%
$23.76
IONQ
-3.09%
$67.28
BB
+6.66%
$4.96
JOBY
+1.57%
$16.11
NOK
-0.42%
$4.66
AMD
-1.12%
$159.46
CRWV
-4.98%
$120.34
CLF
+2.48%
$12.37
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BTE
+2.43%
$2.52
QS
+1.28%
$12.66
WLGS
-5.57%
$0.04
HIMS
+6.43%
$58.40
AQMS
+48.37%
$7.30
ABEV
0.00%
$2.29
MRVL
-0.76%
$83.17
ETWO
0.00%
$3.30
ORCL
-2.70%
$283.45
HBAN
+0.57%
$17.42
HOOD
-0.70%
$121.78
AG
+4.02%
$12.14
NWTN
-15.63%
$2.04
AIIO
-15.63%
$2.04
SDM
-86.40%
$1.85
T
+0.03%
$28.31
OKLO
-7.21%
$110.53
ITUB
+0.55%
$7.24
MU
+0.28%
$157.27
PCG
+3.67%
$14.97
AFMD
-34.94%
$0.18
WULF
-1.27%
$10.83

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.